CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals announced today that its Chief Executive Officer Nancy Simonian, M.D., will present a corporate overview at the upcoming BioCentury 23rd Annual Future Leaders in the Biotechnology Industry Conference. The Company’s management team will also participate in next week’s Cowen and Company 36th Annual Health Care Conference. Additional details are as follows:
Cowen and Company 36th Annual Health
Date: Monday, March 7 to Wednesday, March 9
Location: The Boston Marriott Copley Place, 110 Huntington Avenue, Boston, Mass.
BioCentury 23rd Annual Future Leaders in the Biotech Industry
Date: Friday, March 11
Time: 2:00 pm ET
Room: Room 311
Location: Millennium Hotel, 145 West 44th Street, New York, NY
About Syros Pharmaceuticals
Syros Pharmaceuticals is a biopharmaceutical company applying a pioneering approach to discover and develop medicines that control the expression of genes with the aim of treating cancer and other serious diseases. Syros has built a proprietary gene control platform that provides the Company with a unique lens to identify crucial genes that become dysregulated in diseased cells. Syros is leveraging its platform to develop a pipeline of gene control product candidates that it believes will provide a profound and durable benefit for patients. The Company’s scientific founders are world-class leaders in gene control research and translation. Launched by Flagship Ventures and ARCH Venture Partners, Syros Pharmaceuticals is located in Cambridge, Mass.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160303005455/en/
Ten Bridge Communications, Inc.
Naomi Aoki, 617-283-4298
Stern Investor Relations, Inc.
Jesse Baumgartner, 212-362-1200
Source: Syros Pharmaceuticals
Released March 3, 2016